Multiple meta-analyses have demonstrated the prognostic significance of tumor-infiltrating lymphocytes (TILs) in breast cancer, especially in triple-negative and HER-2 positive tumors [1, 2]. The gene discussed is ERBB2; the disease is breast carcinoma.